Walleye Capital’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-43,600
Closed -$153K 1070
2020
Q1
$153K Sell
43,600
-90,400
-67% -$766K 0.03% 499
2019
Q4
$1.42M Buy
134,000
+114,200
+577% +$1.01M 0.09% 299
2019
Q3
$222K Buy
19,800
+7,600
+62% +$90K 0.01% 1152
2019
Q2
$112K Buy
+12,200
New +$127K 0.01% 1186

Other funds holding DBD

Walleye Capital's DBD Position: Q1 2023 in Review

Walleye Capital sold out of Diebold Nixdorf Incorporated (DBD) in Q1 2023, closing a stake of 19,408 shares — an estimated $27.6K sold.

Walleye Capital first reported a position in DBD in Q1 2019 and held it in 7 quarters. The position peaked at $1.88M in Q2 2022. 128 funds tracked by Wall St. Rank hold DBD as of Q1 2023.

  • Walleye Capital reported no remaining Diebold Nixdorf Incorporated position as of Q1 2023 after selling out during the quarter.
  • Walleye Capital sold 19,408 Diebold Nixdorf Incorporated shares in Q1 2023, an estimated $27.6K.
  • Walleye Capital first reported a position in Diebold Nixdorf Incorporated in Q1 2019 and held it in 7 quarters.
  • Walleye Capital's Diebold Nixdorf Incorporated position peaked at $1.88M in Q2 2022.
  • 128 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q1 2023.

Based on Walleye Capital's 13F filing for Q1 2023, filed 15 May 2023.